Immunovia AB (FRA:1YR)
€ 0.0338 0.0013 (4%) Market Cap: 8.99 Mil Enterprise Value: 6.59 Mil PE Ratio: 0 PB Ratio: 2.83 GF Score: 42/100

Immunovia AB (publ) - Special Call Transcript

May 13, 2020 / 02:30PM GMT
Operator

Hello, and welcome to Immunovia COVID-19 update #3. My name is Jose, and I will be your coordinator for today's event. Please note that this conference is being recorded. (Operator Instructions)

I will now hand you over to your host, Mats Grahn, CEO, to begin today's conference. Thank you.

Mats Grahn;publ;CEO
Immunovia AB

()-

Thank you. And good afternoon or good morning, depending from where you're calling in from. Welcome to this third update regarding COVID-19 impact on Immunovia's activities. This is of course a changing environment for everyone in the world today, and we want to do a regular update to keep you informed about the status.

Today's focus will be mainly on the steps to launch given the Marlborough and Massachusetts shut down there. And we will also focus on the launch preparations where we are forcefully going forward with digital methods in our launch program.

So let me then -- hopefully you have the slides in front of you while we do this. And as we said, the agenda is the response

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot